Application of the transosseous approach for computed tomography-guided radioactive 125-iodine seed implantation for the treatment of thoracic and abdominal lymph node metastases

Simple item page
dc.contributor.authorChen, Jianen_US
dc.contributor.authorChen, Jinen_US
dc.contributor.authorLin, Xiu-Huaen_US
dc.contributor.authorLin, Rui-Xiangen_US
dc.contributor.authorYan, Yuanen_US
dc.contributor.authorLin, Qing-Fengen_US
dc.contributor.authorLin, Zheng-Yuen_US
dc.date.accessioned2020-11-18T10:07:34Z
dc.date.available2020-11-18T10:07:34Z
dc.date.issued2020-01
dc.description.abstractAim: This study aimed to investigate the technical procedure, safety, and clinical value of the transosseous approach for computed tomography (CT)-guided radioactive 125-iodine (125I) seed implantation for the treatment of thoracic and abdominal lymph node metastases. Subjects and Methods: This was a retrospective study that Nine lymph node metastases in nine patients were treated in our hospital between January 2010 and August 2018. Under CT guidance, at least one puncture path was made through the transosseous approach. The seeds were planted according to the TPS. CT/MRI scans were performed every 2 months after the treatment to evaluate local therapeutic efficacy according to the Response Evaluation Criteria in Solid Tumors. Results: The transosseous approach was successfully established in all patients. The median follow-up time was 11 months (6–36 months). At 2, 4, 6, 8, 10 and 12 months after operation, the objective effective rate and clinical benefit rate were 66.67%, 77.78%, 77.78%, 71.43%, 66.67% and 50.00%; and 88.89%, 88.89%, 88.89%, 71.43%, 66.67% and 50.00%, respectively. The survival rate of the patients at 6, 12, 18, 24, 30 and 36 months after operation was 53.00%, 26.00%, 26.00%, 13.00%, 13.00% and 13.00%, respectively. Conclusions: The transosseous approach for CT-guided radioactive 125I seed implantation was safe, effective, and minimally invasive for the treatment of thoracic and abdominal lymph node metastasesen_US
dc.identifier.affiliationsDepartment of Interventional Radiology, First Affiliated Hospital of Fujian Medical University, Fuzhou, Chinaen_US
dc.identifier.citationChen Jian, Chen Jin, Lin Xiu-Hua, Lin Rui-Xiang, Yan Yuan, Lin Qing-Feng, Lin Zheng-Yu. Application of the transosseous approach for computed tomography-guided radioactive 125-iodine seed implantation for the treatment of thoracic and abdominal lymph node metastases. Journal of Cancer Research and Therapeutics. 2020 Jan; 15(6): 1611-1616en_US
dc.identifier.issn0973-1482
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/213579
dc.languageenen_US
dc.publisherWolters Kluwer India Pvt. Ltd.en_US
dc.relation.issuenumber6en_US
dc.relation.volume15en_US
dc.source.urihttps://dx.doi.org//10.4103/jcrt.JCRT_526_19en_US
dc.subjectBrachytherapyen_US
dc.subjectlymph node metastasesen_US
dc.subjectradioactive 125I seed implantationen_US
dc.subjecttransosseous approachen_US
dc.subjectX-ray computed tomographyen_US
dc.titleApplication of the transosseous approach for computed tomography-guided radioactive 125-iodine seed implantation for the treatment of thoracic and abdominal lymph node metastasesen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Ijcrt2019v15n7p1611.pdf
Size:
882.31 KB
Format:
Adobe Portable Document Format
Download
Collections
Journal of Cancer Research and Therapeutics